Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.
NASDAQEquity ETF
$105.02
−$2.4406 · -2.27%
At close: Oct 8, 4:00 PM ET
$105.32
+$0.3006 · +0.29%
After hours · As of Oct 8, 7:30 PM ET
Regular session · ET · Market data may be delayed.
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.
Fund facts updated Oct 8, 2026.
Day range
Current $105.02
52-week range
Current $105.02
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
1 month
-8.74%
3 months
-2.53%
Year to date
+31.64%
1 year
+60.16%
3 years
+120.63%
5 years
+20.19%
Since inception
+1298.39%
Cumulative price changes exclude distributions and investor-specific taxes, trading costs, and cash flows.
Showing 15 of 247 reported holdings
Displayed portfolio weight: 71.81%
Holdings data updated Oct 8, 2026.
Signed exposures may include leverage or short positions and do not represent ordinary portfolio weights.
Portfolio weights show the assets held by the fund; they do not represent its leveraged or inverse market exposure.
Sep 23, 2026
Sep 23, 2026
Sep 29, 2026
$0.0826
Semiannual
Mar 25, 2026
Mar 25, 2026
Mar 31, 2026
$0.0071
Quarterly
Dec 24, 2025
Dec 24, 2025
Dec 31, 2025
$0.1346
Quarterly
Sep 24, 2025
Sep 24, 2025
Sep 30, 2025
$0.1805
Quarterly
Jun 25, 2025
Jun 25, 2025
Jul 1, 2025
$0.1706
Quarterly
Mar 26, 2025
Mar 26, 2025
Apr 1, 2025
$0.1309
Quarterly
Dec 23, 2024
Dec 23, 2024
Dec 31, 2024
$0.3964
Quarterly
Sep 25, 2024
Sep 25, 2024
Oct 2, 2024
$0.1529
Quarterly
Jun 26, 2024
Jun 26, 2024
Jul 3, 2024
$0.2648
Quarterly
Mar 20, 2024
Mar 21, 2024
Mar 27, 2024
$0.0403
Quarterly
Amounts are shown per share in the ETF trading currency and adjusted for splits when the provider supplies an adjusted value; otherwise the reported amount is used.
